Award notice Supplies

Accord-cadre ayant pour objet la fourniture d'antibactériens par voie injectable

Notice published in French. The AI analysis summarises it for you in your language.

Official notice and documents

Public buyer: Centrale de Négociation pour les Achats Hospitaliers
Erpent
Place of performance: 5101 Erpent
not published: buyer's address
Bids received: 3
Form: Framework agreement
Multi-year contract: the buyer places orders as needs arise.
Procedure: Open procedure
Any company may submit a bid.
Publication: 3 January 2025
Notice language: French

What is the authority looking for?

Supplies · Produits pharmaceutiques, vaccins

Accord-cadre ayant pour objet la fourniture d'antibactériens par voie injectable

Where and when?

5101 Erpent (buyer's address)

Deadline not published in the notice

Site visit and deadline for questions: stated in the specifications, not in the notice.

What budget?

Amount not published in the notice. The AI analysis and comparable tenders give an order of magnitude.

Why is this tender relevant to me?

Create your free account : we compare every tender with your trade and your area.

Can I consider bidding?

The AI analysis extracts the participation conditions, the contractor approval and the required documents. See the analysis and the verdict for your company

Nothing is assumed: what the notice does not say is marked "to check".

What do I need to do?

1. Read the analysis · 2. Check that you meet the conditions · 3. Prepare the response · 4. Submit on the official platform before the deadline.

This tender is no longer open.

AI analysis: go for it or not?

Summary in English, criteria, documents to provide and a GO / NO GO verdict in one minute.

Create my free account

Unlimited analyses during the 14-day Pro trial, no card needed.

Description

Accord-cadre ayant pour objet la fourniture d'antibactériens par voie injectable

Awarded to

13 lots

Amoxicilline + acide clavulanique 500 mg + 50 mg, 1 g + 200 mg et 2 g + 200 mg, IV
Pipéracilline + Tazobactam 4 g + 500 mg, IV
Céfazoline 1 g et 2 g, IV ou IM/IV
Céfuroxime 750 mg et 1500 mg, IV ou IM/IV
Ceftazidime 1 g et 2 g, IV ou IM/IV
Méropénem 1 g, IV
Clindamycine 300 mg et 600 mg, IM/IV
Ciprofloxacine 400 mg, IV
Ciprofloxacine 200 mg, IV
Lévofloxacine 500 mg, IV
Moxifloxacine 400 mg, IV
Vancomycine 500 mg et 1 g, IV
Tigécycline 50 mg, IV

CPV codes

European codes that classify what the contract is about. They are how we find the tenders for your trade.

33600000

Winning prices for comparable contracts

A quarter below: €269,390
Median: €449,863
A quarter above: €962,736

Amounts awarded (excl. VAT) over the last 3 years for 58 contracts in the same CPV group (3360…), excluding framework agreements. Half of the contracts fall between the two quartiles. TED source: mostly contracts above the EU thresholds, so amounts tend to be high.

Similar contracts already awarded

Contract	Winner	Amount
Accord-cadre ayant pour objet la fourniture de produits de contraste iodés et d'agents de diagnostic par résonance magnétique Centrale de Négociation pour les Achats Hospitaliers · 31 December 2025	GUERBET Bayer GE HEALTHCARE Bracco Imaging Europe	€42,237,307
Accord-cadre ayant pour objet la fourniture de Ceftriaxone Centrale de Négociation pour les Achats Hospitaliers · 31 December 2025	Fresenius Kabi	€960,210
Accord-cadre ayant pour objet la fourniture de Palonosétron et d'Ondansétron Centrale de Négociation pour les Achats Hospitaliers · 31 December 2025	Viatris Grindeks Kalceks Belgium ACCORD HEALTHCARE	€761,230
Accord-cadre ayant pour objet la fourniture de Bosutinib Centrale de Négociation pour les Achats Hospitaliers · 31 December 2025	Pfizer	€3,061,220
Accord-cadre ayant pour objet la fourniture de Fingolimod 0,5 mg Centrale de Négociation pour les Achats Hospitaliers · 3 January 2025	Viatris	–

Source : TED – Office des publications de l'Union européenne © Union européenne, données retraitées. Reference 3379-2025.